| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.07B | +6.6% |
| Cost of Revenue | $925.5M | +2.7% |
| R&D Expense | $40.9M | +15.9% |
| SG&A Expense | $458.2M | +12.1% |
| Operating Income | $1.34B | +7.2% |
| Pre-tax Income | $1.17B | -4.7% |
| Income Tax | $263.0M | -5.4% |
| Net Income | $908.3M | -5.2% |
| EPS (Basic) | $6.50 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.18B | +648.0% |
| Accounts Receivable | $422.2M | -2.8% |
| Current Assets | $2.77B | +203.4% |
| Total Assets | $6.20B | +45.3% |
| Current Liabilities | $2.30B | +85.7% |
| Long-term Debt | $4.77B | +54.4% |
| Total Liabilities | $5.89B | +41.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.44B | +25.5% |
| Capital Expenditures | $244.1M | +9.0% |
| Investing Cash Flow | -$358.1M | -186.9% |
| Financing Cash Flow | $795.2M | +177.3% |
| Free Cash Flow | $1.19B | +29.5% |
| -3.6% |
| EPS (Diluted) | $6.48 | -3.4% |
| Stockholders' Equity |
| $309.0M |
| +208.7% |